Cognitive rehabilitation for executive dysfunction in brain tumor patients: a pilot randomized controlled trial.

Nadine M RichardLori J BernsteinWarren P MasonNormand LaperriereCatherine MauriceBarbara-Ann MillarDavid B ShultzAlejandro BerlinKim Edelstein

Published in: Journal of neuro-oncology (2019)

GMT improved executive and real-life functioning in brain tumor survivors, with gains maintained at 4-month follow-up. Clinical implementation of this adaptable program merits consideration for clinically stable patients with cognitive dysfunction. Further development and larger prospective cognitive rehabilitation trials appear warranted.

Keyphrases

end stage renal disease
quality improvement
ejection fraction
chronic kidney disease
primary care
young adults
peritoneal dialysis
randomized controlled trial
study protocol
clinical trial
double blind